Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

932.06 +21.37 (+2.35%)
Official Closing Price Updated: 7:00 PM EDT, Oct 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,293,878
Open 916.04
Bid (Size) 925.00 (1)
Ask (Size) 930.01 (19)
Prev. Close 910.69
Today's Range 911.18 - 932.15
52wk Range 547.61 - 972.53
Shares Outstanding N/A
Dividend Yield 0.48%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 No-Brainer Growth Stocks to Buy in October
These stocks look like slam-dunk picks for growth investors. 
Via The Motley Fool
Got $500? 2 Magnificent Growth Stocks to Buy and Hold Forever
These industry leaders still look like top-notch buys. 
Via The Motley Fool

Performance

YTD
+57.39%
+57.39%
1 Month
+0.90%
+0.90%
3 Month
-1.94%
-1.94%
6 Month
+24.15%
+24.15%
1 Year
+51.15%
+51.15%

More News

Read More
Johnson & Johnson Dividend Stock Analysis - Saturday, Oct. 12
Via Talk Markets
Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names
Via Benzinga
Criminal Networks Cash In On Demand For Weight Loss Drugs, Authorities Say
Via Benzinga
Topics Law Enforcement
Exposures Legal
(LLY) - Analyzing Eli Lilly's Short Interest
Via Benzinga
Sustainability Of Energy Stocks Is Clouded By 2024 Election Uncertainty
Via Investor's Business Daily
Warning: This Skyrocketing Stock Has a Hidden Risk
Via The Motley Fool
FTC Faces Pressure to Block Novo Nordisk-Catalent Merger Over Antitrust Fears
Via Benzinga
Eli Lilly Issues Cease-And-Desist Letters to Compounders Over Weight-Loss Drug Copies As Shortage Resolves
Via Benzinga
Exposures Product Safety
Top 3 Stocks with Explosive Call Option Activity: What to Watch
Via MarketBeat
2 No-Brainer Dividend Growth Stocks to Buy Right Now
Via The Motley Fool
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
Via Benzinga
CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit
Via Benzinga
What's Going With WeightWatchers Stock On Wednesday?
Via Benzinga
Exposures Product Safety
Don’t Sleep on Skye Bioscience—This Weight Loss Drug Could Soar
Via MarketBeat
Why Eli Lilly Was Such a Healthy Stock Today
Via The Motley Fool
FDA Sparks Controversy With Sudden Removal Of Eli Lilly's Weight Loss Drug From Shortage List
Via Benzinga
Exposures Product Safety
Hims & Hers Stock Joins S&P 600: Is More Upside on the Horizon?
Via MarketBeat
Topics Stocks
Exposures US Equities
With Its GLP-1 Drugs No Longer in a Shortage, Is Now the Time to Buy Eli Lilly Stock?
Via The Motley Fool
UNH: A Solid Healthcare Play In A Rotational Market
Via Talk Markets
Billion-Dollar News for Eli Lilly Stock Investors
Via The Motley Fool
Biotech Stocks Poised For Another Big Move In Q4
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Regeneron Chief Flags Health Risks with Popular Weight-Loss Medications Like Ozempic, Says Company Targets Muscle Preservation For Its Obesity Drugs
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.